World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
48
Citations
9554
World Ranking
18329
National Ranking
7486

Michael R. Mattern publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Michael R. Mattern sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 110 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Michael R. Mattern D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Mattern sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 48 D-Index — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Michael R. Mattern is affiliated with the National Institutes of Health in the United States. Their research portfolio spans multiple disciplines, focusing particularly on Medicine and Social Sciences.

The scientist's work crosses various subfields, including Epidemiology, Molecular Biology, Neurology, Management of Technology and Innovation, and Sociology and Political Science. This interdisciplinary approach reflects in the diversity of topics addressed in their publications.

Michael R. Mattern has contributed to the following main research topics:

  • Autophagy in Disease and Therapy
  • Ubiquitin and Proteasome Pathways
  • Parkinson's Disease Mechanisms and Treatments
  • Digital Innovation in Industries
  • Innovation, Technology, and Society
  • Vocational Education and Training
  • Water Resources Management and Optimization

Their recent publications include:

  • The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's Disease, 2023, NeuroMolecular Medicine
  • Innovationslabor Digitalisierung - Produktentwicklung mittels Design Thinking im Makerspace, 2023, Industrie 4.0 Management

Their coauthors have included:

  • Suresh Kumar
  • Matthew S. Goldberg
  • Tauseef R. Butt
  • Sebastian Bast
  • K. Scherer

Michael R. Mattern's frequent publication venues are NeuroMolecular Medicine and Industrie 4.0 Management, indicating engagement with both biomedical and technology management communities.

Best Publications

  • SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins

    Michael P Malakhov;Michael R Mattern;Oxana A Malakhova;Mark Drinker

  • SUMO fusion technology for difficult-to-express proteins

    Tauseef R. Butt;Suzanne C. Edavettal;John P. Hall;Michael R. Mattern

  • Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.

    Robert P. Hertzberg;Mary Jo Caranfa;Kenneth G. Holden;Dalia R. Jakas

  • Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II

    Fred H. Drake;Glenn A. Hofmann;Henry F. Bartus;Michael R. Mattern

  • Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

    Priya Chaturvedi;Wai K Eng;Yuan Zhu;Michael R Mattern

  • Caffeine Abolishes the Mammalian G2/M DNA Damage Checkpoint by Inhibiting Ataxia-Telangiectasia-mutated Kinase Activity *

    Bin-Bing S. Zhou;Priya Chaturvedi;Kevin Spring;Shaun P. Scott

  • In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.

    Susan J. Berners-Price;Christopher K. Mirabelli;Randall K. Johnson;Michael R. Mattern

  • The Identification and Characterization of the Marine Natural Product Scytonemin as a Novel Antiproliferative Pharmacophore

    Christopher S. Stevenson;Elizabeth A. Capper;Amy K. Roshak;Brian Marquez

  • 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.

    Lara S. Kallander;Qing Lu;Wenfang Chen;Thaddeus Tomaszek

  • Human tumor cell strains defective in the repair of alkylation damage.

    Rufus S. Day;Chuck H.J. Ziolkowski;Dominic A. Scudiero;Sharon A. Meyer

  • Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).

    Michael R. Mattern;Glenn A. Hofmann;Francis L. McCabe;Randall K. Johnson

  • Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II

    Jon Minford;Yves Pommier;Jan Filipski;Kurt W. Kohn

  • Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells.

    Michael R. Mattern;Shau Ming Mong;Henry F. Bartus;Christopher K. Mirabelli

  • Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47.

    Weinstock J;Wu J;Cao P;Kingsbury Wd

  • Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas.

    Dominic A. Scudiero;Sharon A. Meyer;Brian E. Clatterbuck;Michael R. Mattern

  • Enhanced expression and purification of membrane proteins by SUMO fusion in Escherichia coli.

    Xun Zuo;Shuisen Li;John Hall;Michael R. Mattern

  • Deubiquitinating Enzymes as Novel Anticancer Targets

    Benjamin Nicholson;Jeffrey G Marblestone;Tauseef R Butt;Michael R Mattern

  • Reduced Formation of Protein-associated DNA Strand Breaks in Chinese Hamster Cells Resistant to Topoisomerase II Inhibitors

    Yves Pommier;Ronald E. Schwartz;Leonard A. Zwelling;Donna Kerrigan

  • Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities

    Benjamin Nicholson;Craig A. Leach;Seth J. Goldenberg;Dana M. Francis

  • Dependence of mammalian DNA synthesis on DNA supercoiling. III Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and nalidixic acid

    Michael R. Mattern;Dominic A. Scudiero

Frequent Co-Authors

Jian Wu
Jian Wu Fudan University
Leonard A. Zwelling
Leonard A. Zwelling The University of Texas MD Anderson Cancer Center
Yves Pommier
Yves Pommier National Institutes of Health
Kurt W. Kohn
Kurt W. Kohn National Institutes of Health
Wayne W. Hancock
Wayne W. Hancock University of Pennsylvania
Dominic A. Scudiero
Dominic A. Scudiero Science Applications International Corporation (United States)
Daniel F. Veber
Daniel F. Veber GlaxoSmithKline (United Kingdom)
Taku Kambayashi
Taku Kambayashi University of Pennsylvania
Stanley T. Crooke
Stanley T. Crooke Ionis Pharmaceuticals (United States)
Ronald H. Schwartz
Ronald H. Schwartz National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your career possibilities in Biology and Biochemistry often means looking beyond a traditional degree. There are a variety of online programs designed for those interested in healthcare, nutrition, and advanced practice roles.

For those aiming to specialize in mental health, consider the shortest pmhnp certificate program. This option allows registered nurses to quickly earn credentials as a Psychiatric Mental Health Nurse Practitioner. Alternatively, nurses with a master’s degree can advance their practice efficiently through the cheapest post master's fnp program, providing a cost-effective pathway to become a Family Nurse Practitioner.

If nutrition and public health are of interest, pursuing a dietician degree online can be an excellent fit. These degrees can prepare you for roles in clinical nutrition, wellness programs, or the food industry. Many registered nurses also choose to broaden their opportunities—and earning potential—by enrolling in online rn to bsn programs that provide convenient and flexible learning options.

Exploring allied online degrees in health and science fields can open new career pathways and help you meet the evolving demands of the healthcare sector.

Best Scientists Citing Michael R. Mattern

Trending Scientists

Recently Published Articles